|Bid||51.87 x 800|
|Ask||51.90 x 1200|
|Day's Range||51.58 - 52.09|
|52 Week Range||34.29 - 54.49|
|Beta (5Y Monthly)||1.41|
|PE Ratio (TTM)||39.65|
|Earnings Date||Feb 11, 2020|
|Forward Dividend & Yield||0.16 (0.31%)|
|Ex-Dividend Date||Nov 28, 2019|
|1y Target Est||54.50|
Bruker has a 98 Composite Rating and earns the No. 4 rank among its peers in the Medical-Systems/Equipment industry group.
The stock market took a breather Tuesday, after news emerged that some tariffs in the U.S.-China deal wouldn't be made until after the election.
Bruker (BRKR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 38th annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO and Gerald Herman, CFO will present on behalf of the company on Monday, January 13th, 2020 at 11:30 AM Pacific Time.
Bruker Corporation (Nasdaq: BRKR) today announced that it has completed certain debt financing actions intended to enhance its financial flexibility and fund corporate strategic objectives. The actions include: (1) a new 5 year revolving credit facility with expanded capacity to borrow up to $600 million, (2) a new 7 year term loan in the aggregate principal amount of $300 million, together with cross-currency and interest rate swap arrangements which fix rates to Euro and Swiss Franc rates, (3) a new private placement of 10 year senior notes in the aggregate principal amount of 297 million Swiss Franc, and (4) new cross-currency swap arrangements on existing 2012 private placement notes of $205 million which fix rates to Euro and Swiss Franc rates. This debt refinancing capitalizes on the low interest rate environment in domestic and European capital markets, effectively fixes interest rates on approximately 60% of the Company's total borrowing capacity and extends debt maturities out to 2026 and 2029.
At the 2019 joint meeting of the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO), Bruker (Nasdaq: BRKR) today announced the launch of the Luxendo TruLive3D Imager light-sheet imaging system. The new system features dual-sided illumination and highly efficient light collection for fast imaging of a broad range of biological samples in their native 3D environments. The TruLive3D Imager leverages the general benefits of single-plane illumination microscopy (SPIM) to enable rapid 3D imaging with minimal light exposure, confocal resolution and excellent contrast in 3D. An extended sample chamber enables multi-sample experiments and an integrated environmental chamber ensures long-term live observations of even the most delicate samples such as stem cells, primary human cells and organoids.
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
Is Bruker Corporation (NASDAQ:BRKR) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, unconventional data sources, expert networks, and get tips from investment bankers and industry insiders. Sure they sometimes fail miserably, but their consensus […]
The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
Is Owens Corning (NYSE:OC) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors, who employ world-class Ivy League graduates, who are given immense resources and industry contacts to put their financial expertise to work. […]
BILLERICA, Mass. , Nov. 15, 2019 /PRNewswire/ -- Bruker Corporation (Nasdaq: BRKR) announced today it will present at the following conferences: Stifel 2019 Healthcare Conference, New York , NY Tuesday, ...
BILLERICA, Mass. , Nov. 14, 2019 /PRNewswire/ -- Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per ...